REGISTERED NUMBER: 08655709 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD

1 SEPTEMBER 2023 TO 31 DECEMBER 2024

FOR

UNITE MEDICAL LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

N A Romeo

A J Hollingsworth

REGISTERED OFFICE:

631 Milton Keynes Business Centre

Foxhunter Drive

Linford Wood

Milton Keynes

Buckinghamshire

MK14 6GD

REGISTERED NUMBER:

08655709 (England and Wales)

ACCOUNTANTS:

TC Group

Baird House

Seebeck Place

Knowlhill

Milton Keynes

Buckinghamshire

MK5 8FR

FIXED ASSETS

Tangible assets

4

25,021

20,958

CURRENT ASSETS

Debtors

5

830,283

1,531,250

Cash at bank and in hand

27,806

25,082

858,089

1,556,332

CREDITORS

Amounts falling due within one year

6

875,179

1,452,099

NET CURRENT (LIABILITIES)/ASSETS

(17,090

)

104,233

TOTAL ASSETS LESS CURRENT LIABILITIES

7,931

125,191

PROVISIONS FOR LIABILITIES

8

6,255

5,240

NET ASSETS

1,676

119,951

CAPITAL AND RESERVES

Called up share capital

9

125

125

Retained earnings

1,551

119,826

SHAREHOLDERS' FUNDS

1,676

119,951

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 September 2025 and were signed on its behalf by:

N A Romeo - Director

1.	STATUTORY INFORMATION

Unite Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Office equipment

-

25% on cost

Software

-

10% on reducing balance

Taxation

Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was 18 (2023 - 20 ) .

4.	TANGIBLE FIXED ASSETS

Office

equipment

Software

Totals

£

£

£

COST

At 1 September 2023

56,260

15,277

71,537

Additions

3,358

10,000

13,358

At 31 December 2024

59,618

25,277

84,895

DEPRECIATION

At 1 September 2023

43,019

7,560

50,579

Charge for period

7,683

1,612

9,295

At 31 December 2024

50,702

9,172

59,874

NET BOOK VALUE

At 31 December 2024

8,916

16,105

25,021

At 31 August 2023

13,241

7,717

20,958

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade debtors

640,236

1,257,416

Other debtors

28,555

28,526

Directors' current accounts

12,076

-

Prepayments and accrued income

149,416

245,308

830,283

1,531,250

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Payments on account

410,798

837,492

Trade creditors

42,269

76,403

Corporation tax

27,351

47,085

Social security and other taxes

10,234

20,042

VAT

284,946

306,269

Other creditors

88,919

153,652

Directors' current accounts

-

624

Accrued expenses

10,662

10,532

875,179

1,452,099

7.	SECURED DEBTS

The following secured debts are included within creditors:

2024

2023

£

£

Payments on account

410,798

837,492

During the 16 month period, the company changed invoice discounting provider from Investec Factoring to Lloyd's Invoice Finance. At 31 December 2024 the payments on account facility with Lloyd's Invoice Finance, is secured against the trade receivables of the company.

8.	PROVISIONS FOR LIABILITIES

2024

2023

£

£

Deferred tax

6,255

5,240

Deferred

tax

£

Balance at 1 September 2023

5,240

Accelerated capital allowances

1,015

Balance at 31 December 2024

6,255

9.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2024

2023

value:

£

£

75

Ordinary A

£1

75

75

50

Ordinary B

£1

50

50

125

125

10.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

At 31 December 2024, there was £12,076 owed from director's (August 2023: £624 owed to director's), within a directors current account. This is due to be repaid to the company within 9 months of the period end of 31 December 2024.

11.	RELATED PARTY DISCLOSURES

During the 16 month period, office expenses of £nil (2023: £7,189) have been recharged to Vantage Healthcare Recruitment Limited, of which N Romeo and A Hollingsworth and both directors and shareholders.

12.	PENSION COMMITMENTS

The company operates a defined contribution pension scheme for the employees (including directors). The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £13,034 (2023: £10,107). Contributions totalling £4,116 (2023: £2,089) were payable to the fund at the balance sheet date and are included in other creditors.